NCT02994563 - Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

February 25, 2021

Study Completion Date

March 1, 2021

Conditions

Ischemic Stroke

Interventions

DEVICE

Thrombectomy Device

The Amnis Thrombectomy Device is intended to restore blood flow by removing thrombus from intracranial vessels in patients experiencing ischemic stroke

Trial Locations (4)

47003

Hospital Clínico Universitario (Valladolid); Dept. Neurology, Valladolid

08035

Hospital Vall d'Hebron; Unidad Ictus, Barcelona

08036

Hospital Clinico of Barcelona; Section of Vascular Radiology & Neuroradiology, Barcelona

171 76

Karolinska Universitetssjukhuset i Solna, Stockholm